Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes, National Health Interview Survey, United States, 2021 and 2022
RESEARCH BRIEF — Volume 21 — November 14, 2024
Updated November 14, 2024
PEER REVIEWED
Figure.
Unadjusted prevalence of telemedicine use in the past 12 months among adults with and without diagnosed prediabetes or diabetes. Prevalence (%) and associated 95% CIs are weighted; error bars indicate 95% CIs. For each population, differences between 2021 and 2022 were significant (all P< .05). Source: National Health Interview Survey, 2021 and 2022.
| Diagnosis | 2021 | 2022 |
|---|---|---|
| % (95% CI) | ||
| No diagnosed prediabetes or diabetes | 34.1 (33.3–35.0) | 28.2 (27.4–29.1) |
| Diagnosed prediabetes | 47.6 (45.4–49.8) | 37.6 (35.3–40.0) |
| Diagnosed diabetes | 52.8 (50.6–54.9) | 39.4 (37.2–41.6) |